Allergan plc
DelistedCIK 1578845fmd_1EEKH1HXJ1PR0X05JTWQSPR0TZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Mar 31, 2020, 34 periods
Latest annual · FY2019
Millions- Total revenues
- 16,089
- Gross profit
- 13,596
- Operating income
- (4,445)
- Net income
- (5,271)
- Free cash flow
- 6,864
Latest quarter · Q1 FY2020
Millions- Total revenues
- 3,604
- Gross profit
- 2,981
- Operating income
- (1,300)
- Net income
- 378
- Free cash flow
- 56
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2016 to FY2019
- +3.4%
- Revenue, 5 yearsFY2014 to FY2019
- +28.0%
- Net income, 5 yearsFY2014 to FY2019
- n/m
Allergan plc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Revenue | $16.1 billion | $15.8 billion | +1.9% | 10-K 2020-02-18 · proof |
| Gross profit | $13.6 billion | $13.6 billion | 0% | 10-K 2020-02-18 · proof |
| Operating income | -$4.4 billion | -$6.2 billion | 10-K 2020-02-18 · proof | |
| Net income | -$5.3 billion | -$5.1 billion | 10-K 2020-02-18 · proof | |
| Cash from operating activities | $7.2 billion | $5.6 billion | +28.3% | 10-K 2020-02-18 · proof |
| Free cash flow | $6.9 billion | $5.4 billion | +27.4% | 10-K 2020-02-18 · proof |
| Total assets | $94.7 billion | $101.8 billion | -7% | 10-K 2020-02-18 · proof |
| Total liabilities | $36.5 billion | $36.7 billion | -0.4% | 10-K 2020-02-18 · proof |
| Cash and cash equivalents | $2.5 billion | $880.4 million | +184.3% | 10-K 2020-02-18 · proof |
| Total debt | $22.6 billion | $23.8 billion | -4.8% | 10-K 2020-02-18 · proof |
- What was Allergan plc's revenue in fiscal 2019?
- Allergan plc reported revenue of $16.1 billion for fiscal 2019 (the year ended Dec 31, 2019), against $15.8 billion the year before (+1.9%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What was Allergan plc's gross profit in fiscal 2019?
- Allergan plc reported gross profit of $13.6 billion for fiscal 2019 (the year ended Dec 31, 2019), against $13.6 billion the year before (0%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What was Allergan plc's operating income in fiscal 2019?
- Allergan plc reported operating income of -$4.4 billion for fiscal 2019 (the year ended Dec 31, 2019), against -$6.2 billion the year before. Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What was Allergan plc's net income in fiscal 2019?
- Allergan plc reported net income of -$5.3 billion for fiscal 2019 (the year ended Dec 31, 2019), against -$5.1 billion the year before. Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What was Allergan plc's cash from operating activities in fiscal 2019?
- Allergan plc reported cash from operating activities of $7.2 billion for fiscal 2019 (the year ended Dec 31, 2019), against $5.6 billion the year before (+28.3%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What was Allergan plc's free cash flow in fiscal 2019?
- Allergan plc reported free cash flow of $6.9 billion for fiscal 2019 (the year ended Dec 31, 2019), against $5.4 billion the year before (+27.4%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What are Allergan plc's total assets?
- As of Dec 31, 2019, Allergan plc reported total assets of $94.7 billion, against $101.8 billion a year earlier (-7%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What are Allergan plc's total liabilities?
- As of Dec 31, 2019, Allergan plc reported total liabilities of $36.5 billion, against $36.7 billion a year earlier (-0.4%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What are Allergan plc's cash and cash equivalents?
- As of Dec 31, 2019, Allergan plc reported cash and cash equivalents of $2.5 billion, against $880.4 million a year earlier (+184.3%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
- What is Allergan plc's total debt?
- As of Dec 31, 2019, Allergan plc reported total debt of $22.6 billion, against $23.8 billion a year earlier (-4.8%). Source: the 10-K filed with the SEC on Feb 18, 2020. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1578845&period_type=annual&limit=5"Information only, not investment advice.